🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
The suppression of the immune system creates a permissive environment for d...
Status
Unknown
Location
Multiple Locations
Start Date
2017-08-05
Trial ID
NCT03214718
Maintain and monitor long-term hematological and cytogenetic responses prev...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-08
Trial ID
NCT00786812
Treatments Being Tested
The purpose of this prospective, single-institution observational study is ...
Status
Completed
Location
UNC Hospital
Start Date
2019-06-20
Trial ID
NCT03885830
The purpose of this study is to determine whether nilotinib is efficacious ...
Status
Completed
Location
City of Hope National Medical Center City of Hope national Med Ctr
Start Date
2010-06
Trial ID
NCT01028222
The main purpose of this study was to evaluate the rate of deep molecular r...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-02-18
Trial ID
NCT02546674
Treatments Being Tested
The purpose of this study is to determine the survival, disease response, a...
Status
Completed
Location
The Rebecca and John Moores UCSD Cancer Center
Start Date
2010-04-21
Trial ID
NCT01140568
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
This is an institutional cohort study. Patients confirmed with spinocerebel...
Status
Completed
Location
Seoul National University Hospital
Start Date
2018-11-19
Trial ID
NCT03932669
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested